Skip to main content

Advertisement

Table 1 Propensity score matched data

From: Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

  Rivaroxaban only (n = 52) Rivaroxaban + IA TXA (n = 52) p-value
Age (years)a 70.4 (68.0–72.9) 72.0 (70.0–74.0) 0.320
Male:Femaleb 6: 46 8: 44 0.775
BMI (kg/m2)a 25.1 (24.2–26.1) 25.0 (24.4–25.7) 0.816
ASA-PS classificationa 2.1 (1.9–2.2) 2.1 (2.0–2.3) 0.704
Preoperative Hb (g/dL)a 12.5 (12.1–12.9) 12.6 (12.2–13.0) 0.630
  1. IA TXA Intraarticular tranexamic acid, BMI Body mass index, ASA-PS American Society of Anesthesiologists Physical Status, Hb Haemoglobin
  2. aValues presented as means (95% confidence interval) and compared by independent t-tests
  3. bValues presented as proportions and compared using Pearson’s chi-square test